Type 2 Diabetes Mellitus — Reducing Plasma Glucose Effect of Cinnamon in Type 2 Diabetic Patients in the Municipality of Comasagua
Citation(s)
A S. Alanazi, M. U. Khan. Cinnamon use in type 2 diabetes an updated meta analysis. World Journal of Pharmacy and Pharmaceutical Sciences 4(05):1838-52, 2015.
American Diabetes Association (2) Classification and diagnosis of diabetes. Diabetes Care. 2015 Jan;38 Suppl:S8-S16. doi: 10.2337/dc15-S005. Review.
American Diabetes Association 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64. doi: 10.2337/dc18-S006. Review.
B K. M. Goud, B. Nayal, O. S. Devi, T. G. Sathisha, S. Shivashanker and R. N. Devaki. Relation of calculated HbA1C with fasting plasma glucose and duration of diabetes. International Journal of Applied Biology and Pharmaceutical Technology. 2011;2(2):58-61.
Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology. 1996 Jan;137(1):354-66.
Canivell S, Gomis R Diagnosis and classification of autoimmune diabetes mellitus. Autoimmun Rev. 2014 Apr-May;13(4-5):403-7. doi: 10.1016/j.autrev.2014.01.020. Epub 2014 Jan 11. Review.
Cao H, Polansky MM, Anderson RA Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys. 2007 Mar 15;459(2):214-22. Epub 2007 Jan 25.
Chen L, Magliano DJ, Zimmet PZ The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011 Nov 8;8(4):228-36. doi: 10.1038/nrendo.2011.183. Review.
Costello RB, Dwyer JT, Saldanha L, Bailey RL, Merkel J, Wambogo E Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. J Acad Nutr Diet. 2016 Nov;116(11):1794-1802. doi: 10.1016/j.jand.2016.07.015. Epub 2016 Sep 8. Review.
Cramer JA A systematic review of adherence with medications for diabetes. Diabetes Care. 2004 May;27(5):1218-24. Review.
Dijkstra R, Braspenning J, Grol R Empowering patients: how to implement a diabetes passport in hospital care. Patient Educ Couns. 2002 Jun;47(2):173-7.
E E.-D. Gaber. Antidiabetic and hypolipidemic effects of Ceylon cinnamon (Cinnamomum verum) in alloxan-diabetic rats. Journal of Medicinal Plants Research 6(9): 1685-91, 2012.
Feller S, Boeing H, Pischon T Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. Dtsch Arztebl Int. 2010 Jul;107(26):470-6. doi: 10.3238/arztebl.2010.0470. Epub 2010 Jul 2.
Guthrie RA, Guthrie DW Pathophysiology of diabetes mellitus. Crit Care Nurs Q. 2004 Apr-Jun;27(2):113-25. Review.
Hlebowicz J, Hlebowicz A, Lindstedt S, Björgell O, Höglund P, Holst JJ, Darwiche G, Almér LO Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr. 2009 Mar;89(3):815-21. doi: 10.3945/ajcn.2008.26807. Epub 2009 Jan 21.
I Yépez, R. García and T. Toledo. Complicaciones agudas: Crisis hiperglucémica. Revista Venezolana de Endocrinología y Metabolismo 10:75-83, 2012.
Johnson AM, Olefsky JM The origins and drivers of insulin resistance. Cell. 2013 Feb 14;152(4):673-84. doi: 10.1016/j.cell.2013.01.041.
Klonoff DC ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed. J Diabetes Sci Technol. 2014 May;8(3):439-43. doi: 10.1177/1932296814529638. Epub 2014 Apr 30.
Leach MJ, Kumar S Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD007170. doi: 10.1002/14651858.CD007170.pub2. Review.
Lu T, Sheng H, Wu J, Cheng Y, Zhu J, Chen Y Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res. 2012 Jun;32(6):408-12. doi: 10.1016/j.nutres.2012.05.003. Epub 2012 Jun 14.
M L. Casas Oñate and D. Montoya Martínez. ¿Son fiables los medidores de glucemia capilar?. Avances en Diabetología 28(5):110-3, 2012.
Mahmoodnia L, Aghadavod E, Rafieian-Kopaei M Ameliorative impact of cinnamon against high blood pressure; an updated review. Journal of Renal Injury Prevention 6(3):171-6, 2017.
Medagama AB The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials. Nutr J. 2015 Oct 16;14:108. doi: 10.1186/s12937-015-0098-9. Review.
N G. Vailianou, A. Evangelopoulos, A. Kolia and C. Kazazis. Hypoglycemic and hipolipidemic effects of cinnamon. Current Topics in Nutraceutical Research. 2014;12(4):127-34
Pessin JE, Saltiel AR Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest. 2000 Jul;106(2):165-9. Review.
R A. Anderson. Cinnamon and Glucose Homeostasis. Nutrition Today. 2014;49(Supplement):S10-S1.
R D. Cervantes-Villagrana and J. M. Presno-Bernal. Fisiopatología de la diabetes y los mecanismos de muerte de las células ß pancreáticas. Revista de Endocrinología y Nutrición 21(3):98-106, 2013.
Rao PV, Gan SH Cinnamon: a multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014;2014:642942. doi: 10.1155/2014/642942. Epub 2014 Apr 10. Review.
Ros Pérez M, Medina-Gómez G [Obesity, adipogenesis and insulin resistance]. Endocrinol Nutr. 2011 Aug-Sep;58(7):360-9. doi: 10.1016/j.endonu.2011.05.008. Epub 2011 Jul 22. Review. Spanish.
Sacks DB Correlation between hemoglobin A1c (HbA1c) and average blood glucose: can HbA1c be reported as estimated blood glucose concentration? J Diabetes Sci Technol. 2007 Nov;1(6):801-3.
Sacks DB Measurement of hemoglobin A(1c): a new twist on the path to harmony. Diabetes Care. 2012 Dec;35(12):2674-80. doi: 10.2337/dc12-1348. Review.
Sahib AS Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial. J Intercult Ethnopharmacol. 2016 Feb 21;5(2):108-13. doi: 10.5455/jice.20160217044511. eCollection 2016 Mar-Apr.
Saltiel AR, Kahn CR Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001 Dec 13;414(6865):799-806.
Sami W, Ansari T, Butt NS, Hamid MRA Effect of diet on type 2 diabetes mellitus: A review. Int J Health Sci (Qassim). 2017 Apr-Jun;11(2):65-71. Review.
Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated Receptors. PPAR Res. 2008;2008:581348. doi: 10.1155/2008/581348. Epub 2008 Dec 11.
Zare R, Nadjarzadeh A, Zarshenas MM, Shams M, Heydari M Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial. Clin Nutr. 2019 Apr;38(2):549-556. doi: 10.1016/j.clnu.2018.03.003. Epub 2018 Mar 11.
Hypoglycemic Effect of Cinnamomum Verum in Type 2 Diabetic Patients in the Municipality of Comasagua
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.